The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
Open accessAbstract
2',3'-Dideoxy-5-fluoro-3'-thiacytidine (FTC) has been shown to be a potent and selective compound against human immunodeficiency virus type 1 in acutely infected primary human lymphocytes. FTC is also active against human immunodeficiency virus type 2, simian immunodeficiency virus, and feline immunodeficiency virus in various cell culture systems, including human monocytes. The antiviral activity can be prevented by 2'-deoxycytidine, but not by other natural nucleosides, suggesting that FTC must be phosphorylated to be active and 2'-deoxycytidine kinase is responsible for the phosphorylation. By using chiral columns or enzymatic techniques, the two enantiomers of FTC were separated. The (-)-beta-enantiomer of FTC was about 20-fold more potent than the (+)-beta-enantiomer against human immunodeficiency virus type 1 in peripheral blood mononuclear cells and was also effective in thymidine kinase-deficient CEM cells. Racemic FTC and its enantiomers were nontoxic to human lymphocytes and other cell lines at concentrations of up to 100 microM. Studies with human bone marrow cells indicated that racemic FTC and its (-)-enantiomer had a median inhibitory concentration of > 30 microM. The (+)-enantiomer was significantly more toxic than the (-)-enantiomer to myeloid progenitor cells. The susceptibilities to FTC of pretherapy isolates in comparison with those of posttherapy 3'-azido-3'-deoxythymidine-resistant viruses in human lymphocytes were not substantially different. Similar results were obtained with well-defined 2',3'-dideoxyinosine- and nevirapine-resistant viruses. (-)-FTC-5'-triphosphate competitively inhibited human immunodeficiency virus type 1 reverse transcriptase, with an inhibition constant of 2.9 microM, when a poly(I)n.oligo(dC)19-24 template primer was used. These results suggest that further development of the (-)-Beta-enantiomer of FTC is warranted as an antiviral agent for infections caused by human immunodeficiency viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
The determination of enzyme inhibitor constants
Dixon, M. (1953) · Biochemical Journal · doi:10.1042/bj0550170 · Cited by 4,069
Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase
St. Clair, M. H., Martin, J. L., Tudor-Williams, G., Bach, M. C., Vavro, C. L., King, D. M., Kellam, P., Kemp, S. D., & Larder, B. A. (1991) · Science · doi:10.1126/science.1716788 · Cited by 679
Self-citationDoong, S. L., Tsai, C. H., Schinazi, R. F., Liotta, D. C., & Cheng, Y. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8495 · Cited by 516
Self-citationRichman, D., Shih, C. K., Lowy, I., Rose, J., Prodanovich, P., Goff, S., & Griffin, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11241 · Cited by 393
A molecular clone of HTLV-III with biological activity
Fisher, A. G., Collalti, E., Ratner, L., Gallo, R. C., & Wong-Staal, F. (1985) · Nature · doi:10.1038/316262a0 · Cited by 316
Coates, J. A., Cammack, N., Jenkinson, H. J., Mutton, I. M., Pearson, B. A., Storer, R., Cameron, J. M., & Penn, C. R. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.202 · Cited by 288
Schinazi, R. F., Chu, C. K., Peck, A., McMillan, A., Mathis, R., Cannon, D., Jeong, L. S., Beach, J. W., Choi, W. B., & Yeola, S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.3.672 · Cited by 265
Self-citation[53] Determination of fragment order through partial digests and multiple enzyme digests
Danna, K. J. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65055-1 · Cited by 241
Coates, J. A., Cammack, N., Jenkinson, H. J., Jowett, A. J., Jowett, M. I., Pearson, B. A., Penn, C. R., Rouse, P. L., Viner, K. C., & Cameron, J. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.733 · Cited by 240
Soudeyns, H., Yao, X. I., Gao, Q., Belleau, B., Kraus, J. L., Nguyen-Ba, N., Spira, B., & Wainberg, M. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1386 · Cited by 237
Schinazi, R. F., Sommadossi, J. P., Saalmann, V, Cannon, D. L., Xie, M. Y., Hart, G. C., Smith, G. A., & Hahn, E. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1061 · Cited by 173
Self-citationAntibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U)
Elwell, L. P., Ferone, R., Freeman, G. A., Fyfe, J. A., Hill, J. A., Ray, P. H., Richards, C. A., Singer, S. C., Knick, V. B., & Rideout, J. L. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.274 · Cited by 160
Insights Into HIV Chemotherapy*
Schinazi, R. F., Mead, J. R., & Feorino, P. M. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.963 · Cited by 114
Self-citationMutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine
Remington, K. M., Chesebro, B. W., Wehrly, K., Pedersen, N. C., & North, T. W. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.308-312.1991 · Cited by 89
Sommadossi, J., CARLISLE, R., Schinazi, R. F., & Zhou, Z. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.997 · Cited by 87
Self-citationDornsife, R. E., Clair, M. H. S., Huang, A. T., Panella, T. J., Koszalka, G. W., Burns, C. L., & Averett, D. R. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.2.322 · Cited by 80
North, T. W., Cronn, R., Remington, K. M., & Tandberg, R. T. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.8.1505 · Cited by 58
Eriksson, B., CHU, C. K., & Schinazi, R. F. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1729 · Cited by 51
Self-citationSchinazi, R. F., Chou, T., Scott, R., Yao, X., & Nahmias, A. J. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.3.491 · Cited by 50
Self-citationSchinazi, R. F., Cannon, D. L., Arnold, B. H., & Martino-Saltzman, D. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.12.1784 · Cited by 43
Self-citationAnti-HIV compound assessment by two novel high capacity assays
Averett, D. R. (1989) · Journal of Virological Methods · doi:10.1016/0166-0934(89)90159-6 · Cited by 35
Prevention of Activation of HIV-1 by Antiviral Agents in OM-10.1 Cells
Feorino, P. M., Butera, S. T., Folks, T. M., & Schinazi, R. F. (1993) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029300400107 · Cited by 19
Self-citationPharmacologic Studies of Nucleosides Active against the Human Immunodeficiency Virusa
Sommadossi, J., Zhou, Z., CARLISLE, R., XIE, M., & Weidner, D. A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17856.x · Cited by 7
Self-citation
Cited by
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
Tisdale, M., Kemp, S. D., Parry, N. R., & Larder, B. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5653 · Cited by 603
Seley-Radtke, K. L., & Yates, M. K. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.04.004 · Cited by 543
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
Cihlar, T., & Ray, A. S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.014 · Cited by 375
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Mehellou, Y., & De Clercq, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900492g · Cited by 368
Metadata
- Authors
- Schinazi, R. F., McMillan, A., Cannon, D., Mathis, R., Lloyd, R. M., Peck, A., Sommadossi, J. P., St Clair, M., Wilson, J., & Furman, P. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1992-11
- Volume
- 36
- Issue
- 11
- Pages
- 2423-2431
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1992921405
- Cited by
- 294
- References
- 25
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.